3,098 press releases indexed under healthcare.
Report highlights clean energy, innovation and ESG recognition ZIBO, China, July 13, 2026 /PRNewswire/ -- INTCO Medical ("the Company"), a leading global manufacturer of disposable gloves, has released its 2025 Environmental, Social and Governance (ESG) Report, outlining progress in...
CARACAS, VENEZUELA - July 13, 2026 ( NEWMEDIAWIRE ) - LataMed AI Corp. (OTC: LMED) (the “Company”), a development-stage digital health and artificial intelligence technology company focused on telehealth infrastructure, healthcare analytics, and care coordination solutions for emerging markets, today announced that management has begun planning for the Company's anticipated attendance at the World Health Expo 2027 in Dubai, United Arab Emirates, as part of its broader strategy to evaluate international healthcare expansion opportunities. Management believes attendance at World Health Expo 2027 will provide an important opportunity to engage with healthcare leaders, technology innovators, healthcare providers, government representatives, and potential strategic partners from around the worl
Donations far lower than needed as hospitals work to protect patient care News Summary: The American Red Cross is declaring an emergency blood shortage after the national blood supply fell about 25% in June. Red Cross blood distributions to hospitals are nearly 3,500 units higher per week...
Monday 13 July, 2026 England midfielder Declan Rice, still recovering from a virus, played 45 minutes in 33+ degree heat during the Quarter Final match against Norway on Saturday night. Fans noted he was clearly struggling and wished him well on social media. His commitment was widely praised, but for people living with post-viral illness and Myalgic Encephalomyelitis (M.E.), the moment was deeply concerning. When a national figure pushes through illness in extreme conditions, it reinforces a powerful cultural message: that exertion during or after viral infection is harmless, even admirable. For many people, it is not. For some, it leads to lifelong disability. This moment exposes a critical failure in UK public health communication, specifically the Chief Medical Officer’s physical activ
NANJING, China, July 13, 2026 /PRNewswire/ -- Nanjing Leads Biolabs Co., Ltd. ("Leads Biolabs" or the "Company," Stock Code: 9887.HK) today announced that six of its latest research studies have been accepted for presentation at the 2026 European Society for Medical Oncology (ESMO) Annual...
As demand for accessible youth mental health services rise across Australia, MLA Psychology strengthens its clinical offering with the appointment of neuroaffirming child and adolescent psychologist Tahlia Rahme. [PR.com]
(PR-inside.com) Investigators update from BLAZE in checkpoint-resistant solid tumors highlights continued progress across Faron's expanding Investigator-Initiated Trial (IIT) portfolio TURKU, FI / ACCESS Newswire / July 13, 2026 / Faron Pharmaceuticals Ltd. (HEL:FARON)(LSE:FARN), a global, clinical-stage biopharmaceutical company focused on creating innovative cancer treatments that leverage the patient's own immune system, today provides an update on its portfolio of Investigator-Initiated Trials (IITs) evaluating bexmarilimab, its wholly owned anti-Clever-1 immunotherapy, in multiple oncology indications. The update covers five IITs in solid tumors and hematological malignancies, reflecting both advances and adjustments across the program. BLAZE: Investigators update combination treatmen
(PR-inside.com) LONDON, UK / ACCESS Newswire / July 13, 2026 / Genflow Biosciences Plc (LSE:GENF)(OTCQB:GENFF) ("Genflow" or the "Company"), an emerging leader in the field of longevity research, provides a mid-year operational and corporate summary covering the six-month period to 30 June 2026. No delays in the dog clinical trial: Positive preliminary interim results from the SLAB trial, followed by confirmation of sustained safety and efficacy at the three-month follow-up Expansion of confidentiality agreements with additional Tier-1 animal health companies Strategic technology collaboration with Acuitas Therapeutics ("Acuitas ") for fully funded, non-dilutive LNP delivery development International patent publication extending SIRT6 protection into muscular disease indications New ..
Health Canada NOC enables treatment for porphyria, metabolic disorder Health Canada NOC enables treatment for porphyria, metabolic disorder
STOCKHOLM, July 13, 2026 /PRNewswire/ -- BioArctic AB's (publ) (Nasdaq Stockholm: BIOA B) partner Eisai today presented new data at the 2026 Alzheimer's Association International Conference (AAIC), held in London, July 12-15, demonstrating that the Leqembi (lecanemab) subcutaneous...
LONDON, July 13, 2026 /PRNewswire/ -- The Alzheimer's Association today announced the launch of the PROTECT-Cog Study (Prevention of Risk fOr cogniTive dEcline through Combined Therapy), a first-of-its-kind global clinical trial designed to evaluate whether combining a proven multidomain...
- LatAm-FINGERS Study Findings Confirm and Expand U.S. POINTER Trial Results - - Show Structured Dementia Risk Reduction Strategies Adaptable Across Cultures - Key Takeaways The LatAm-FINGERS study shows lifestyle interventions adapted across Latin American cultures, health systems and...